A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
Clinical trial NCT07203001 · RECRUITING
Trial details
- NCT number
- NCT07203001
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-03
- Primary completion
- 2027-04-22
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.